TNF-α Induction of GM2 Expression on Renal Cell Carcinomas Promotes T Cell Dysfunction
Open Access
- 15 May 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 178 (10) , 6642-6652
Abstract
Previous studies from our laboratory demonstrated the role of tumor-derived gangliosides as important mediators of T cell apoptosis, and hence, as one mechanism by which tumors evade immune destruction. In this study, we report that TNF-α secreted by infiltrating inflammatory cells and/or genetically modified tumors augments tumor-associated GM2 levels, which leads to T cell death and immune dysfunction. The conversion of weakly apoptogenic renal cell carcinoma (RCC) clones to lines that can induce T cell death requires 3–5 days of TNF-α pretreatment, a time frame paralleling that needed for TNF-α to stimulate GM2 accumulation by SK-RC-45, SK-RC-54, and SK-RC-13. RCC tumor cell lines permanently transfected with the TNF-α transgene are similarly toxic for T lymphocytes, which correlates with their constitutively elevated levels of GM2. TNF-α increases GM2 ganglioside expression by enhancing the mRNA levels encoding its synthetic enzyme, GM2 synthase, as demonstrated by both RT-PCR and Southern analysis. The contribution of GM2 gangliosides to tumor-induced T cell death was supported by the finding that anti-GM2 Abs significantly blocked T cell apoptosis mediated by TNF-α-treated tumor cells, and by the observation that small interfering RNA directed against TNF-α abrogated GM2 synthase expression by TNF-transfected SK-RC-45, diminished its GM2 accumulation, and inhibited its apoptogenicity for T lymphocytes. Our results indicate that TNF-α signaling promotes RCC-induced killing of T cells by stimulating the acquisition of a distinct ganglioside assembly in RCC tumor cells.Keywords
This publication has 44 references indexed in Scilit:
- Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma XenograftsCancer Research, 2005
- The immunology of colorectal cancerSurgical Oncology, 2004
- An Assay of Ganglioside Using Fluorescence Image Analysis on a Thin-Layer Chromatography PlateAnalytical Chemistry, 2003
- von Hippel-Lindau Protein-Mediated Repression of Tumor Necrosis Factor Alpha Translation Revealed through Use of cDNA ArraysMolecular and Cellular Biology, 2003
- Vascular endothelial growth factor overexpression is correlated with von Hippel‐Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinomaCancer, 2002
- Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumorJournal of Cancer Research and Clinical Oncology, 2002
- Down-regulation of Fas-Associated Phosphatase-1 (FAP-1) in Interleukin-2-Activated T CellsCellular Immunology, 1998
- Systemic Interleukin-2 Modulates the Anti-Idiotypic Response to Chimeric Anti-GD2 Antibody in Patients with MelanomaJournal of Immunotherapy, 1996
- Interleukins increase surface ganglioside expression of pancreatic islet cells in vitroAPMIS, 1992
- Heterogeneity of tumour necrosis factor production in renal cell carcinomaEuropean Journal of Cancer, 1992